Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
VODCA is developed by MSS Medical Software Solutions GmbH in Switzerland and is positioned as an on-premise clinical and research knowledge management system (KMS) and decision support system (DSS) for radiotherapy. Its core focus is not general-purpose SaaS collaboration, but helping radiotherapy departments build longitudinal patient databases and clinical outcome databases, with workflows around data collection, analysis, storage, and reporting.
Based on the information available on its pages, VODCA includes a DICOM Server, database management system, statistical computing package, and applications such as VODCA-DS, VODCA-RT, VODCA-BATCH, VODCA-DATABASE, and VODCA-R. It supports DICOM, HL7, and PACS RT data conversion, can import RT data from proprietary formats or proprietary databases, and provides batch processing, automated workflows, and “1 Click & Go” script execution. Use cases include plan quality control, comparative plan statistics, biological modeling, clinical outcome research, and multicenter clinical trials.
The public materials do not disclose plans, pricing, a free version, trials, or payment methods. In terms of deployment, VODCA appears closer to an on-premise/self-hosted software package: databases can be stored on local or remote PCs and servers, data storage is supported across all operating systems, and the software environment mentions Windows OS, with installation possible via user-side installers. The pages do not clearly describe a cloud-hosted SaaS option.
VODCA supports centralized, decentralized, or federated data collection for clinical trials. Databases can be backed up, copied, merged, anonymized, and shared via templates, and concurrent user access is supported. Its security philosophy emphasizes reducing the movement of patient data, bringing analysis to where the data resides rather than centralizing raw data. On the developer side, it provides an API for research and ad hoc analysis, but there is no clear mention of an SDK, permission model, audit logs, or compliance certifications.
Its strengths are its strong specialization for radiotherapy scenarios, support for multi-vendor equipment, hospital IT integration, and clinical research workflows. Its decentralized trial concept is also well suited to environments involving sensitive medical data. The downsides are the limited public commercial information, lack of transparency around pricing, service support, and compliance qualifications, and a relatively high professional barrier to adoption. It is better suited to radiation oncology departments, medical physics teams, statistical researchers, and clinical trial collaboration networks, rather than general enterprise knowledge bases or generic data analytics teams.
Website accessibility, network stability, and payment methods in mainland China are unknown. If a local medical institution is evaluating it, key points to confirm include support for a Chinese-language environment, compliance requirements for domestic servers or local deployment, restrictions on cross-border medical data transfer, and interface compatibility with domestic PACS, HIS, LIS, and radiotherapy equipment systems. Comparable options may include Varian ARIA, Elekta MOSAIQ, RaySearch RayCare, or hospital-built research database solutions.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on vodca.ch official site.
vodca.ch is an Switzerland Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach vodca.ch directly.